Amyris, Inc. – NASDAQ:AMRS

Amyris stock price today

$0.052
+0.00
+4%
Financial Health
0
1
2
3
4
5
6
7
8
9

Amyris stock price monthly change

-95.83%
month

Amyris stock price quarterly change

-91.46%
quarter

Amyris stock price yearly change

-98.59%
year

Amyris key metrics

Market Cap
N/A
Enterprise value
1.28B
P/E
-0.66
EV/Sales
4.76
EV/EBITDA
-2.68
Price/Sales
1.36
Price/Book
-0.76
PEG ratio
N/A
EPS
-1.83
Revenue
268.22M
EBITDA
-521.74M
Income
-628.26M
Revenue Q/Q
-2.81%
Revenue Y/Y
20.45%
Profit margin
-195.86%
Oper. margin
-219.63%
Gross margin
4.14%
EBIT margin
-219.63%
EBITDA margin
-194.52%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Amyris stock price history

Amyris stock forecast

Amyris financial statements

Amyris, Inc. (NASDAQ:AMRS): Profit margin
Jun 2022 65.20M -108.54M -166.47%
Sep 2022 71.12M -167.27M -235.17%
Dec 2022 75.80M -150.66M -198.76%
Mar 2023 56.08M -201.77M -359.78%
Amyris, Inc. (NASDAQ:AMRS): Debt to assets
Jun 2022 789440000 1.03B 130.86%
Sep 2022 754060000 1.15B 153.68%
Dec 2022 824932000 1.29B 156.7%
Mar 2023 679679000 1.32B 195.35%
Amyris, Inc. (NASDAQ:AMRS): Cash Flow
Jun 2022 -147.04M -41.93M 3.26M
Sep 2022 -133.53M -30.08M 81.28M
Dec 2022 -92.87M -4.39M 142.90M
Mar 2023 -90.00M -4.81M 41.61M

Amyris alternative data

Amyris

Amyris, Inc. (NASDAQ:AMRS): Google Trends - Amyris
4 Aug 2024 22
11 Aug 2024 16
18 Aug 2024 18
25 Aug 2024 19
1 Sep 2024 17
8 Sep 2024 19
15 Sep 2024 17
22 Sep 2024 13
29 Sep 2024 14
6 Oct 2024 13
13 Oct 2024 10
20 Oct 2024 11
27 Oct 2024 11
3 Nov 2024 14
10 Nov 2024 15
17 Nov 2024 14
24 Nov 2024 14
1 Dec 2024 14
8 Dec 2024 16
15 Dec 2024 22

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

Amyris, Inc. (NASDAQ:AMRS): Job openings
Aug 2023 5
Sep 2023 5
Oct 2023 13
Nov 2023 16
Dec 2023 18
Jan 2024 22
Feb 2024 21
Apr 2024 15
May 2024 13
Jun 2024 12
Jul 2024 8
Dec 2024 12
Jan 2025 9
Feb 2025 19
May 2025 18
Jul 2025 18
Aug 2025 19
Amyris, Inc. (NASDAQ:AMRS): Employee count
Aug 2023 1,598
Sep 2023 1,598
Oct 2023 1,598
Nov 2023 1,598
Dec 2023 1,598
Jan 2024 1,598
Feb 2024 1,598
Mar 2024 1,598
Apr 2024 1,598
May 2024 1,598
Jun 2024 1,598
Jul 2024 1,598

Amyris other data

42.75% -7.49%
of AMRS is owned by hedge funds
138.38M -8.63M
shares is hold by hedge funds

Amyris, Inc. (NASDAQ:AMRS): Insider trades (number of shares)
Period Buy Sel
Jul 2022 0 55576
Aug 2022 17155 0
Sep 2022 0 3788592
Apr 2023 0 231368
Jun 2023 0 20999
Transaction Date Insider Security Shares Price per share Total value Source
Sale
KIEFTENBELD HERMANUS officer: CHIEF FI.. Common Stock 17,499 $0.95 $16,624
Sale
KIEFTENBELD HERMANUS officer: CHIEF FI.. Common Stock 3,500 $0.95 $3,325
Sale
ALVAREZ EDUARDO officer: CHIEF OP.. Common Stock 231,368 $1.23 $284,351
Option
ALVAREZ EDUARDO officer: CHIEF OP.. Common Stock 492,000 N/A N/A
Option
ALVAREZ EDUARDO officer: CHIEF OP.. Performance-based Restricted Stock Units 492,000 N/A N/A
Sale
KUNG FRANK director
Common Stock 36,488 $3.5 $127,708
Sale
KUNG FRANK director
Common Stock 72,972 $3.6 $262,699
Sale
KUNG FRANK director
Common Stock 327,028 $3.6 $1,177,301
Sale
KUNG FRANK director
Common Stock 197,148 $3.8 $749,162
Sale
KUNG FRANK director
Common Stock 883,528 $3.8 $3,357,406
Patent
Application
Filling date: 31 Jul 2020 Issue date: 8 Sep 2022
Application
Filling date: 9 Mar 2022 Issue date: 11 Aug 2022
Grant
Filling date: 11 Mar 2020 Issue date: 19 Jul 2022
Grant
Filling date: 12 Sep 2018 Issue date: 19 Jul 2022
Application
Filling date: 3 Nov 2021 Issue date: 19 May 2022
Application
Filling date: 13 Mar 2020 Issue date: 28 Apr 2022
Grant
Filling date: 27 Jun 2019 Issue date: 26 Apr 2022
Application
Filling date: 23 Jan 2020 Issue date: 7 Apr 2022
Grant
Filling date: 18 May 2017 Issue date: 5 Apr 2022
Grant
Filling date: 2 Jan 2020 Issue date: 25 Jan 2022
Tuesday, 17 September 2024
https://www.prnewswire.com
Friday, 11 August 2023
Reuters
InvestorPlace
Thursday, 10 August 2023
Investopedia
InvestorPlace
Monday, 7 August 2023
Seeking Alpha
Tuesday, 11 July 2023
The Motley Fool
Monday, 3 July 2023
Seeking Alpha
Thursday, 29 June 2023
PennyStocks
Tuesday, 27 June 2023
Seeking Alpha
Wednesday, 7 June 2023
PennyStocks
Tuesday, 6 June 2023
PennyStocks
Thursday, 1 June 2023
PennyStocks
Friday, 19 May 2023
Zacks Investment Research
Monday, 1 May 2023
Benzinga
Friday, 28 April 2023
PennyStocks
Monday, 24 April 2023
InvestorPlace
Wednesday, 19 April 2023
Seeking Alpha
Monday, 17 April 2023
MarketBeat
Monday, 10 April 2023
Zacks Investment Research
Friday, 17 March 2023
Zacks Investment Research
Thursday, 16 March 2023
Seeking Alpha
Wednesday, 15 March 2023
Zacks Investment Research
Tuesday, 14 March 2023
PennyStocks
Wednesday, 22 February 2023
PennyStocks
Friday, 17 February 2023
InvestorPlace
Monday, 13 February 2023
InvestorPlace
Monday, 23 January 2023
PennyStocks
Thursday, 12 January 2023
Seeking Alpha
Monday, 19 December 2022
PennyStocks
  • What's the price of Amyris stock today?

    One share of Amyris stock can currently be purchased for approximately $0.05.

  • When is Amyris's next earnings date?

    Unfortunately, Amyris's (AMRS) next earnings date is currently unknown.

  • Does Amyris pay dividends?

    No, Amyris does not pay dividends.

  • What is Amyris's stock symbol?

    Amyris, Inc. is traded on the NASDAQ under the ticker symbol "AMRS".

  • What is Amyris's primary industry?

    Company operates in the Basic Materials sector and Chemicals - Specialty industry.

  • How do i buy shares of Amyris?

    Shares of Amyris can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Amyris's key executives?

    Amyris's management team includes the following people:

    • Mr. John G. Melo Pres, Chief Executive Officer & Director(age: 59, pay: $1,340,000)
    • Mr. Eduardo Alvarez Chief Operating Officer(age: 61, pay: $959,760)
    • Mr. Hermanus Kieftenbeld Chief Financial Officer & Chief Admin. Officer(age: 59, pay: $817,840)
    • Ms. Nicole Kelsey Gen. Counsel & Sec.(age: 58, pay: $541,530)
  • How many employees does Amyris have?

    As Jul 2024, Amyris employs 1,598 workers.

  • When Amyris went public?

    Amyris, Inc. is publicly traded company for more then 14 years since IPO on 28 Sep 2010.

  • What is Amyris's official website?

    The official website for Amyris is amyris.com.

  • Where are Amyris's headquarters?

    Amyris is headquartered at 5885 Hollis Street, EmeryVille, CA.

  • How can i contact Amyris?

    Amyris's mailing address is 5885 Hollis Street, EmeryVille, CA and company can be reached via phone at +51 04500761.

Amyris company profile:

Amyris, Inc.

amyris.com
Exchange:

NASDAQ

Full time employees:

1,598

Industry:

Chemicals - Specialty

Sector:

Basic Materials

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

5885 Hollis Street
EmeryVille, CA 94608

CIK: 0001365916
ISIN: US03236M2008
CUSIP: 03236M200